We chose ARDS and UC animal models to characterize the ability of PR1P to improve outcome because both these diseases are induced by tissue injury and are characterized by local inflammation and VEGF dysregulation (2, 15, 19). The gene discussed is VEGFA; the disease is acute respiratory distress syndrome.